SC 13G
SABBY 13G CANG 5.22.19
- Company
- Can-Fite BioPharma Ltd.
- Filed
- May 22, 2019
- Accession Number
- 0001535610-19-000087
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →